Table 2.
Molecular assay | Target | No. of replicates detected/total no. of replicates at each dilution expressed by GE/mL (% positive rate) |
Probit (±95% CI),∗ GE/mL | Final LOD,† GE/mL | |||||
---|---|---|---|---|---|---|---|---|---|
4000 | 2000 | 1000 | 500 | 250 | 125 | ||||
NWHL LDT | S | 4/4 | 6/6 (100) | 9/10 (90) | 5/10 (50) | 2/8 (25) | 1/8 (25) | 1301 ± 13 | 1301 ± 13 |
Modified CDC assay | N1 | 4/4 | 6/6 (100) | 9/10 (90) | 7/10 (70) | 6/8 (75) | 1/8 (25) | 1249 ± 14 | 1249 ± 14 |
N2 | 4/4 | 6/6 (100) | 10/10 (100) | 5/10 (50) | 2/8 (25) | 1/8 (25) | 946 ± 11 |
GE/mL, genome equivalents/mL; LOD, limit of detection; NWHL LDT, Northwell Health Laboratories laboratory-developed test.
Upper/lower (±) 95% CI.
The final LODs were based on both assays’ results interpretation algorithm and determined by using probit analysis.